Posts with tag Medicines

Sort by Latest
HMA-EMA publish multi-annual AI workplan: further guidance on the use of AI in the medicines lifecycle
In December 2023, the joint HMA-EMA Big Data Steering Group (BDSG) published a multi-annual (2023-2028) AI workplan to guide use of AI in medicines development. The HMA and EMA recognize that pharmaceutical companies are increasingly using AI-powered tools in research, development and monitoring medicines. In this workplan it is stated that the aim is to embrace the opportunities of AI for personal productivity, automating processes and systems, increasing insights into data and supporting more robust...
January 16, 2024
4 min read
European Commission proposes to change the rules on...
This article is part of a series that covers the proposed...
June 15, 2023
4 min read
Post-Transition Brexit: New MHRA Guidelines on Med...
With a post-transition Brexit looming on the horizon, the Medicines...
September 30, 2020
7 min read